“We’re not just an OEM. We’re a true development and manufacturing partner for life sciences innovators,” said Bryan Bothwell, Executive Vice President of Life Sciences at G&H. “Our new Innovation Hub in Rochester is purpose-built to translate ideas into commercially viable devices - faster, more cost-effectively, and with fewer handoffs.”
A New Era for North American Medtech Innovation
Opened in May 2025, G&H’s Rochester facility bridges the gap between R&D and production, helping medtech innovators reduce time-to-market. The site integrates engineering, regulatory consultancy, and manufacturing under one roof and supports high-volume medical consumables production with capacity exceeding 100 million units per year.
This strategic expansion builds on G&H’s 45-year foundation in the UK, bringing its proven model of vertically integrated life sciences development to the North American market.